Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1082 | 1011 | 1082 | 1226 | 1445 | 2699 |
Fund Return | 8.19% | 1.07% | 8.19% | 7.03% | 7.63% | 10.44% |
Place in category | 919 | 888 | 919 | 387 | 393 | 67 |
% in Category | 63 | 56 | 63 | 33 | 43 | 11 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
NG Fund Institutional Accumulation | 124.93M | 7.91 | 6.76 | 10.16 | ||
NG Income Fund Institutional Income | 251.63K | 7.92 | 6.76 | 10.16 | ||
Income Fund B Accumulation | 16.34M | 8.03 | 6.86 | 10.25 | ||
Income Fund Sterling Accumulation | 4.11M | 7.33 | 6.16 | 9.54 | ||
Income Fund B Income | 53.11M | 8.03 | 6.86 | 10.25 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Guinness Global Equity Income Z | 6.86B | 14.82 | 8.71 | 11.68 | ||
Income Fund X Accumulation | 91.47M | 9.01 | 7.83 | 11.26 | ||
NG Fund Institutional Accumulation | 124.93M | 7.91 | 6.76 | 10.16 | ||
NG Income Fund Institutional Income | 251.63K | 7.92 | 6.76 | 10.16 | ||
Income Fund Sterling Accumulation | 4.11M | 7.33 | 6.16 | 9.54 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
CME Group | US12572Q1058 | 3.35 | 242.53 | +0.78% | |
Cisco | US17275R1023 | 3.26 | 61.34 | +0.49% | |
Sanofi | FR0000120578 | 2.89 | 102.68 | -1.70% | |
Johnson Controls | IE00BY7QL619 | 2.27 | 77.29 | +0.38% | |
PepsiCo | US7134481081 | 2.26 | 143.49 | -4.51% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review